论文部分内容阅读
目的观察分析万托林与普米克联合治疗小儿哮喘急性发作的应用功效。方法 86例哮喘急性发作患儿,采用单双数形式将其分为对照组与观察组,每组43例。对照组予以单纯万托林治疗,观察组在对照组的基础上联合普米克进行治疗,对两组治疗的有效性进行观察对比。结果观察组总有效率(97.67%)明显优于对照组(88.37%),差异具有统计学意义(P<0.05);治疗后两组最大呼气流量(PEF)变异率均得到显著改善(P<0.05),且观察组PEF变异率较对照组改善更明显(P<0.05)。结论万托林联合普米克治疗小儿哮喘急性发作效果理想,能显著提高PEF变异率,具有较高的临床应用价值。
Objective To observe and analyze the combined effect of etoposide and pumicek in the treatment of acute attack of childhood asthma. Methods Totally 86 children with acute asthma were divided into control group and observation group with 43 cases in each group. The control group was treated with pure vetollin. The observation group was treated with Pulmicort on the basis of the control group, and the effectiveness of the two groups was observed and compared. Results The total effective rate (97.67%) in observation group was significantly better than that in control group (88.37%), the difference was statistically significant (P <0.05). After treatment, the maximum expiratory flow rate (PEF) <0.05), and the PEF mutation rate in the observation group was more significant than that in the control group (P <0.05). Conclusion Vetolin combined Pulimic treatment of acute asthma in children with an ideal effect, can significantly improve the mutation rate of PEF, with high clinical value.